Skip to content

The effect of Dietary Approaches to Stop Hypertension diet on mental health

Investigating the effect of Dietary Approaches to Stop Hypertension diet on stress, depression, quality of life and sleep status of students and their families: A randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210427051098N1
Enrollment
400
Registered
2021-10-10
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Anxiety. Condition 3: Sleep disorders. Condition 4: Dyspepsia. Condition 5: Irritable bowel syndrome. Condition 6: Stress. Condition 7: Quality of life. Mood disorder due to known physiological condition with depressive features Anxiety disorder due to known physiological condition Sleep disorders not due to a substance or known physiological condition Functional dyspepsia Irritable bowel syndrome Psychological and behavioral factors associated with di

Interventions

Intervention 1: Intervention group: in this group, the individuals will receive dietary approach to stop hypertension (DASH) diet which including 18% protein, 27% fat and 55% carbohydrate. At first, t

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Undergraduate nutrition students and their families (over 12 years old) Completion of informed consent

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Suffering from cancer Suffering from autoimmune diseases Suffering from inflammatory bowel disease Chronic or acute kidney disease (creatinine = 1.4 mg / dL for men or = 1.3 for women or proteinuria) Hospitalization for more than 2 weeks

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: DASS-21 validated questionnaire.;Depression. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: Beck and DASS-21 validated questionnaires.;Sleep quality. Timepoint: Before the intervention, 6 months after the intervention. Method of measurement: Pittsburgh Validated Questionnaire.;Stress. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: DASS-21 validated questionnaire.;Quality of life. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: SF-12 validated questionnaire.;Excessive daytime sleepiness. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Epworth Sleepiness Scale validated questionnaire.;Dyspepsia. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Rome IV questionnaire.;Irritable bowel syndrome. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Rome IV questionnaire.

Secondary

MeasureTime frame
Weight. Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Weighting scale.;Body mass index (BMI). Timepoint: Before the intervention, 6 and 12 months after the intervention. Method of measurement: Ratio of weight to height squared.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayyed Saeid Khayyatzadeh

Shahid Sadoughi University of Medical Sciences

khayyatzadeh@yahoo.com+98 35 3820 9100

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026